DE2521197C2 - 1-(2-Deoxy-β-D-erythro-pentofuranosyl)-5,6-dihydro-5-methyl-s-triazin-2,4(1H,3H)-dion und Derivate - Google Patents

1-(2-Deoxy-β-D-erythro-pentofuranosyl)-5,6-dihydro-5-methyl-s-triazin-2,4(1H,3H)-dion und Derivate

Info

Publication number
DE2521197C2
DE2521197C2 DE2521197A DE2521197A DE2521197C2 DE 2521197 C2 DE2521197 C2 DE 2521197C2 DE 2521197 A DE2521197 A DE 2521197A DE 2521197 A DE2521197 A DE 2521197A DE 2521197 C2 DE2521197 C2 DE 2521197C2
Authority
DE
Germany
Prior art keywords
compound
carboxylic acid
dihydro
preparation
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2521197A
Other languages
German (de)
English (en)
Other versions
DE2521197A1 (de
Inventor
Brian Kalamazoo Mich. Bannister
Clarence Deboer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE2521197A1 publication Critical patent/DE2521197A1/de
Application granted granted Critical
Publication of DE2521197C2 publication Critical patent/DE2521197C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/903—Streptomyces platensis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2521197A 1974-05-20 1975-05-13 1-(2-Deoxy-β-D-erythro-pentofuranosyl)-5,6-dihydro-5-methyl-s-triazin-2,4(1H,3H)-dion und Derivate Expired DE2521197C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US471322A US3907779A (en) 1974-05-20 1974-05-20 5,6 Dihydro-5-azathymidine and derivatives

Publications (2)

Publication Number Publication Date
DE2521197A1 DE2521197A1 (de) 1975-12-11
DE2521197C2 true DE2521197C2 (de) 1984-09-13

Family

ID=23871167

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2521197A Expired DE2521197C2 (de) 1974-05-20 1975-05-13 1-(2-Deoxy-β-D-erythro-pentofuranosyl)-5,6-dihydro-5-methyl-s-triazin-2,4(1H,3H)-dion und Derivate

Country Status (9)

Country Link
US (1) US3907779A (enExample)
JP (2) JPS5851759B2 (enExample)
BE (1) BE829268A (enExample)
CA (1) CA1037889A (enExample)
DE (1) DE2521197C2 (enExample)
FR (1) FR2271838B1 (enExample)
GB (1) GB1472667A (enExample)
NL (1) NL7505708A (enExample)
ZA (1) ZA752598B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022889A (en) * 1974-05-20 1977-05-10 The Upjohn Company Therapeutic compositions of antibiotic U-44,590 and methods for using the same
US3988314A (en) * 1975-10-10 1976-10-26 The Upjohn Company Compound U-50,228, derivatives thereof, and processes for preparation
US4171431A (en) * 1976-08-19 1979-10-16 The Upjohn Company Nucleosides and process
US4140850A (en) * 1977-08-29 1979-02-20 The Upjohn Company 2,2'-Anhydrotriazine nucleosides and process for preparing the same
US4239753A (en) * 1978-12-12 1980-12-16 The Upjohn Company Composition of matter and process
US4477442A (en) * 1978-12-12 1984-10-16 The Upjohn Company Composition of matter and process
US4423212A (en) * 1980-12-18 1983-12-27 The Upjohn Company Nucleosides and process
JPH04150878A (ja) * 1990-10-16 1992-05-25 Goerling George ゴルフスイング教習装置
AU649116B2 (en) * 1991-03-27 1994-05-12 Sankyo Company Limited New compounds, named the "Leustroducins", their preparation and their therapeutic uses
US5711853A (en) * 1993-06-16 1998-01-27 Ranpak Corp. Paper strengthened with solubilized collagen and method
US5316942A (en) * 1993-06-16 1994-05-31 Battelle Memorial Institute Process for the production of low-cost soluble high-molecular weight collagen
US5700353A (en) * 1993-06-16 1997-12-23 Ranpak Corporation Paper strengthened with solubilized collagen and method
US5700354A (en) * 1993-06-16 1997-12-23 Ranpak Corp. Paper strengthened with solubilized collagen and method
US20070207973A1 (en) * 2002-09-24 2007-09-06 Koronis Pharmaceuticals, Incorporated 1,3,5-Triazines for Treatment of Viral Diseases
AU2003278904A1 (en) * 2002-09-24 2004-04-19 Kornis Pharmaceuticals, Incorporated 1, 3, 5-triazines for treatment of viral diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3300478A (en) * 1965-06-01 1967-01-24 Upjohn Co Arabinofuranosyl 2', 5'-and 3'-5'-dinucleoside phosphates and process therefor
US3457253A (en) * 1965-06-01 1969-07-22 Upjohn Co 5',5'-di-(ara)-nucleoside phosphates

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT

Also Published As

Publication number Publication date
JPS50148590A (enExample) 1975-11-28
DE2521197A1 (de) 1975-12-11
ZA752598B (en) 1976-03-31
FR2271838A1 (enExample) 1975-12-19
CA1037889A (en) 1978-09-05
BE829268A (fr) 1975-11-20
AU8057975A (en) 1976-11-04
GB1472667A (en) 1977-05-04
FR2271838B1 (enExample) 1978-10-06
NL7505708A (nl) 1975-11-24
JPS5948072A (ja) 1984-03-19
US3907779A (en) 1975-09-23
JPS5851759B2 (ja) 1983-11-18

Similar Documents

Publication Publication Date Title
DE2552638B2 (de) Thienamycin, Verfahren zu seiner Herstellung und Thienamycin enthaltende Arzneimittel
CH638194A5 (de) Esterastin, eine neue physiologisch wirksame substanz und deren herstellung.
DE2521197A1 (de) Neues antibiotikum
DE2816608A1 (de) Antibiotisches n-acetyl-dehydro- thienamycin
DE2150593C2 (de) Neues Antibiotikum Ws-4545(Bicyclomycin), Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zubereitung
DE1952317A1 (de) 3-Phosphat-Ester von Lincomycin,dessen Analysen und Celestin sowie Verfahren zu deren Herstellung
DE2652677C2 (de) Antibiotica 890A↓1↓ und 890A↓3↓, Verfahren zu ihrer Herstellung und diese Antibiotika enthaltende antibakterielle Mittel
DE3102137A1 (de) Neue antibiotisch wirksame verbindung, komponente b, mikrobiologisches verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2028403B2 (de) Pepstatin
EP0660825B1 (de) Entzündungshemmende makrolactame (cyclamenol)
DE3041130C2 (enExample)
DE2652681C2 (de) N-Acetylthienamycin, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Mittel
DE2353998A1 (de) Antibiotika und verfahren zu deren herstellung
DE2026595A1 (de) Verfahren zur Herstellung von Antibiotika
CH637137A5 (en) Antibiotic and process for its preparation
DE69223302T2 (de) Antibiotikum LL-E19020 Gamma
DE1667923C3 (de) Neue Antibiotika, Verfahren zu ihrer Herstellung sowie pharmazeutische Zubereitung, die diese Antibiotika enthält
DE2450813C2 (de) Antibioticum FR-02A
DE2944143C2 (de) Antibiotikum SF-2052, Verfahren zu dessen Herstellung und das Antibiotikum SF-2052 enthaltende antibakterielle Mittel
DE2316965A1 (de) Proteaseinhibitoren, ihre herstellung und verwendung
DE2329012A1 (de) Aminoglykosidantibiotika und ihre herstellung aus micromonospora
CH629253A5 (en) Process for preparing neothramycin
AT267057B (de) Verfahren zur Herstellung eines neuen Antibiotikums
DE2121248C3 (de) Antibiotikum Axenomycin D mit der Summenformel C78 H125 O3 S Na, und Verfahren zu dessen Herstellung
DE2510161A1 (de) Antibioticum, ein verfahren zu seiner herstellung sowie seine verwendung als arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee